A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Conditions:   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma Interventions:   Drug: Pirtobrutinib;   Drug: Bendamustine;   Drug: Rituximab Sponsor:   Loxo Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2021 Category: Research Source Type: clinical trials

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma
Conditions:   Bendamustine;   Multiple Myeloma Intervention:   Drug: Bendamustine Sponsor:   Liao Aijun Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials